EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Recent advances in nanoparticles targeting TGF-β signaling for cancer treatment

Ziying Li, Xugang Ji, Xiaoyi Cong, Yu Gao, Jianqing Gao

Theranostics · 2026

DOI: 10.7150/thno.126517 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Theranostics, 2026. Verfasst von Ziying Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of the Ministry of Education for Advanced Catalysis Materials, College of Chemistry and Materials Science, Zhejiang Normal University,…. Hauptthemen laut MEDLINE: Transforming Growth Factor beta, Neoplasms, Signal Transduction, Nanoparticles. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple therapies blocking TGF-β signaling have been investigated in preclinical and clinical trials over the past few decades; nevertheless, the outcomes of clinical trials are disappointing due to the double-faced systemic effects of TGF-β and the complexity of the tumor microenvironment. Intelligent nanodelivery systems engineered with responsive stimuli and targeting capabilities address the Janus-faced biology of TGF-β through spatially precise inhibition. Nanoparticles targeting TGF-β reciprocally create a positive feedback loop that enhances the penetration and delivery efficiency of nanoparticles because of the role of TGF-β in remodeling the tumor microenvironment. This review first outlines the function of TGF-β signaling, summarizes various tools for suppressing TGF-β signaling and provides an exhaustive emphasis on advanced nanoparticles targeting TGF-β. This review elucidates the symbiotic interplay between TGF-β blockade and nanoparticles, where nanomaterial-based strategies refine the specificity of TGF-β targeting, while the blockade of TGF-β reciprocally enhances the efficiency of nanoparticle-mediated delivery. Additionally, current challenges and future directions are highlighted to guide the future development of TGF-β blockade strategies and nanoparticles for antitumor therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transforming Growth Factor betaNeoplasmsSignal TransductionNanoparticlesAntineoplastic AgentsDrug Delivery SystemsHumansAnimalsTumor Microenvironment

Stichwörter der Autor:innen

TGF-β blockadecancer treatmentnanocarriernanodrug delivery systemnanoparticle

Substanzen

Transforming Growth Factor betaAntineoplastic Agents

Autor:innen und Institutionen

  • Key Laboratory of the Ministry of Education for Advanced Catalysis Materials, College of Chemistry and Materials Science, Zhejiang Normal University, Jinhua 321004, China.
  • Cancer Metastasis Alert and Prevention Center, College of Chemistry, and Fujian Provincial Key Laboratory of Cancer Metastasis Chemoprevention and Chemotherapy, Fuzhou University, Fuzhou 350108, China.
  • College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.

Zitieren

APA

Li, Z., Ji, X., Cong, X., Gao, Y., & Gao, J. (2026). Recent advances in nanoparticles targeting TGF-β signaling for cancer treatment. Theranostics. https://doi.org/10.7150/thno.126517

Vancouver

Li Z, Ji X, Cong X, Gao Y, Gao J. Recent advances in nanoparticles targeting TGF-β signaling for cancer treatment. Theranostics. 2026. doi:10.7150/thno.126517

BibTeX
@article{Li2026,
  author = {Li, Ziying and Ji, Xugang and Cong, Xiaoyi and Gao, Yu and Gao, Jianqing},
  title = {Recent advances in nanoparticles targeting TGF-β signaling for cancer treatment},
  journal = {Theranostics},
  year = {2026},
  doi = {10.7150/thno.126517}
}
Kostenlos starten →